Artemis Medicare Services Ltd. (ARTEMISMED) 52 Week High Streak: Second Straight Session Near High

Artemis Medicare Services Ltd. (ARTEMISMED) has now traded within 2% of its 52-week high for its second straight session, and the Artemis Medicare Services Ltd. 52 Week High Streak has therefore become the main market focus. Across that streak, the stock has moved up 11.72%, with the latest peak at Rs 371.8 and the current price at Rs 371.8. According to latest Univest data, the pattern is confirmed, but the figures do not establish a company-specific catalyst for the continued move.

As of 28 September 2026 at 2:52 PM IST, the stock was trading at Rs 371.8 versus the previous close of Rs 358, after opening at Rs 361.55 and moving between Rs 351 and Rs 371.8 during the day. The market capitalisation stands at Rs 5,667.36 crore. For readers tracking the Artemis Medicare Services Ltd. 52 Week High Streak, the key point is not a one-off move but the fact that ARTEMISMED has remained close to its yearly high across multiple sessions rather than on a single burst.

Artemis Medicare Services Ltd. 52 Week High Streak: Consecutive High Analysis

Metric	Value
Current Price	Rs 371.8
Previous Close	Rs 358
Today's Move	+Rs 13.8 (+3.85%)
Open	Rs 361.55
High	Rs 371.8
Low	Rs 351
Market Capitalisation	Rs 5,667.36 crore

Artemis Medicare Services Ltd. (ARTEMISMED) traded at Rs 371.8 versus the previous close of Rs 358, a rise of 3.85%. The stock opened at Rs 361.55, reached a high of Rs 371.8 and touched a low of Rs 351.

ARTEMISMED was trading at Rs 371.8, up Rs 13.8 or 3.85% from the previous close of Rs 358. The day open was Rs 361.55, the day low was Rs 351 and the day high was Rs 371.8, which places the current price at the top end of the day’s range. That shape matters for the Artemis Medicare Services Ltd. 52 Week High Streak because it shows the stock has stayed close to its best level during the market hours so far.

For a stock near a yearly high, the share price today is only one part of the picture. The broader read comes from the repeated proximity to the peak across back-to-back sessions, the size of the move across the streak, and the fact that the current price is matching the latest high of the day. The market capitalisation of Rs 5,667.36 crore places ARTEMISMED in the mid-range of the healthcare universe by size, while the repeated near-high pattern keeps the Artemis Medicare Services Ltd. 52 Week High Streak in focus for short-term readers and longer-horizon investors alike.

What the Repeated 52-Week Highs Show

The Artemis Medicare Services Ltd. 52 Week High Streak shows that the stock has remained in the same near-peak zone for two sessions, which is more informative than a single-day headline move. The cumulative 11.72% rise across the streak is the key differentiator here, because it measures how much the stock has advanced over the full multi-session stretch rather than only today’s price change.

This repeated pattern also tells readers that ARTEMISMED has not simply touched a higher level once and moved away from it. Instead, it has continued to trade near the 52-week high, making the Artemis Medicare Services Ltd. 52 Week High Streak a useful market signal for observers who track stocks at one-year highs, back-to-back highs and the broader list of stocks hitting 52 week highs. The latest Univest figures confirm the pattern, but they do not identify a company-specific catalyst behind it.

Because the event is a near-high streak rather than a fresh all-time high, it should be read as a yearly high formation, not a lifetime record. That distinction matters for any ARTEMISMED stock news update or ARTEMISMED stock performance review, since the relevant question is how long the stock can remain near its one-year peak, not whether a new lifetime price mark has been set.

Artemis Medicare Services Ltd. (ARTEMISMED) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 5,667.36 crore
P/E Ratio	49.87x
P/B Ratio	6.32x
ROE	12.72%
ROCE	15.83%
EPS	Rs 7.18
Book Value Per Share	Rs 56.68
Dividend Yield	0.13%

Artemis Medicare Services Ltd. (ARTEMISMED) fundamental metrics show P/E 49.87x, P/B 6.32x, ROE 12.72%, ROCE 15.83%. These figures provide context only and are not a buy or sell signal.

Artemis Medicare Services Ltd. has a market capitalisation of Rs 5667.36 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 49.87x, P/B at 6.32x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.72% and ROCE of 15.83%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 7.18, book value per share of Rs 56.68, dividend yield of 0.13%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 44.07x, median ROE of 12.88%, median ROCE of 15.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Hospital & Healthcare Services
Benchmark Scope	same industry
Company P/E Ratio	49.87x
Benchmark Median P/E	44.07x
Benchmark Average P/E	90.44x
Benchmark P/E Range	0x to 1,602.7x
Company P/B Ratio	6.32x
Benchmark Median P/B	3.22x
Company ROE	12.72%
Benchmark Median ROE	12.88%
Company ROCE	15.83%
Benchmark Median ROCE	15.61%
Company Market Capitalisation	Rs 5,667.36 crore
Benchmark Median Market Cap	Rs 493.16 crore

Artemis Medicare Services Ltd. (ARTEMISMED) is classified under sector: Healthcare and industry: Hospital & Healthcare Services.

Artemis Medicare Services Ltd. (ARTEMISMED) has a P/E ratio of 49.87x, which is above the benchmark median of 44.07x, a difference of +13.16%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Artemis Medicare Services Ltd. (ARTEMISMED) has a ROE of 12.72%, which is below the benchmark median of 12.88%, a difference of -1.24%. Artemis Medicare Services Ltd. (ARTEMISMED) has a ROCE of 15.83%, which is above the benchmark median of 15.61%, a difference of +1.41%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Kovai Medical Center & Hospital Ltd.	KOVAI	6,670.29	26.02	4.8	20.33	22.89
NEPHROCARE HEALTH SERV L	NEPHROPLUS	7,004.94	91.16	6.18	9.22	16.18
Jupiter Life Line Hospitals Ltd.	JLHL	8,689.14	46.32	5.49	13.39	15.7
Thyrocare Technologies Ltd.	THYROCARE	9,008.76	51.1	14.31	29.05	38.3
Indraprastha Medical Corporation Ltd.	INDRAMEDCO	3,355.23	17.85	4.21	27.47	37.7

Artemis Medicare Services Ltd. (ARTEMISMED) has a P/E ratio of 49.87x compared with the displayed peer median of 46.32x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 12.72% compares with a peer median of 20.33% across the companies shown in the table. ROCE stood at 15.83% versus the displayed peer median of 22.89%, providing a capital-efficiency comparison. Artemis Medicare Services Ltd. (ARTEMISMED) has a market capitalisation of Rs 5,667.36 crore. Among the 5 peers shown, 4 have a larger market capitalisation.

Why Investors Are Watching Artemis Medicare Services Ltd.

• The Artemis Medicare Services Ltd. 52 Week High Streak has run for a second straight session.
• ARTEMISMED has moved 11.72% across the streak.
• The stock is trading at Rs 371.8, which matches the latest high of the day.
• The P/E ratio of 49.87 places ARTEMISMED above the industry median.
• The healthcare and hospital services backdrop offers a broad peer set for ARTEMISMED stock analysis.

About Artemis Medicare Services Ltd.

Artemis Medicare Services Ltd. operates in the Hospital & Healthcare Services industry within the Healthcare sector. The company’s market capitalisation is Rs 5,667.36 crore, and its latest valuation and return ratios place it in the middle-to-higher range of the industry’s pricing spectrum. For investors reading the ARTEMISMED stock news flow, the business is being tracked not only for its share price but also for how it is valued against healthcare peers.

The Artemis Medicare Services Ltd. 52 Week High Streak adds a market-pricing layer to that company profile. It gives readers a current reference point for ARTEMISMED share price today, the broader stock performance picture and the company’s position in the healthcare sector.

Frequently Asked Questions

What does the Artemis Medicare Services Ltd. 52 Week High Streak mean?

Ans. It means ARTEMISMED has traded within 2% of its 52-week high for a second straight session. The streak is useful because it shows repeated proximity to the yearly high, not just a one-time move.

How much has ARTEMISMED moved across the streak?

Ans. According to latest Univest data, ARTEMISMED has gained 11.72% across the current streak. That cumulative move is the main difference between a single-day headline and a multi-session high streak.

Is ARTEMISMED at a new all-time high?

Ans. No. The event described here is a near 52-week high streak. A new all-time high should only be used when that specific figure is explicitly available and supported by the numbers.

What is the ARTEMISMED share price today?

Ans. ARTEMISMED was trading at Rs 371.8, up Rs 13.8 or 3.85% from the previous close. The day open was Rs 361.55 and the day low was Rs 351.

How does ARTEMISMED look on valuation?

Ans. The stock is trading at a P/E of 49.87 and a P/B of 6.32. Both are above the industry medians in the hospital and healthcare services set, which puts valuation in focus for stock analysis.

How does ARTEMISMED compare with healthcare peers?

Ans. ARTEMISMED trades at a higher P/E than Kovai Medical Center, Indraprastha Medical Corporation and Jupiter Life Line Hospitals, while staying below some higher-multiple names such as NEPHROCARE HEALTH SERV L and HCG.

Why are investors tracking the Artemis Medicare Services Ltd. 52 Week High Streak?

Ans. Investors often track repeated near-high sessions because they show how long a stock can stay close to a yearly peak. For ARTEMISMED, the key watchpoint is whether the price keeps holding near the current zone.

What should investors monitor next in ARTEMISMED?

Ans. Readers may watch whether the stock continues to remain near its yearly high, how the valuation compares with peers, and whether future market updates change the fundamental picture. The current streak itself confirms the pattern, not the reason behind it.

Track Artemis Medicare Services Ltd. (ARTEMISMED) Share Price on Univest

Use Artemis Medicare Services Ltd. (ARTEMISMED) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.